UPDATED Mar 27, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$421.43 | -0.9% | 50.2% | US$3.1t | US$467.16 | PE37.9x | E12.6% | 0.7% | Software | ||
AAPL | US$173.31 | -3.0% | 7.8% | US$2.7t | US$200.53 | PE26.5x | E4.8% | 0.6% | Tech | ||
GOOGL | US$150.87 | 1.4% | 48.8% | US$1.9t | US$164.59 | PE25.4x | E11.8% | n/a | Media | ||
AMZN | US$179.83 | 0.9% | 79.4% | US$1.9t | US$206.32 | PE61.4x | E22.0% | n/a | Retail | ||
META | US$493.86 | -2.3% | 140.5% | US$1.3t | US$524.03 | PE32.2x | E14.3% | 0.4% | Media | ||
LLY | US$778.18 | 0.7% | 131.7% | US$701.0b | US$797.44 | PE133.8x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,318.73 | -2.2% | 108.1% | US$611.2b | US$1,497.90 | PE52.8x | E23.4% | 1.6% | Semiconductors | ||
JPM | US$199.52 | 1.6% | 54.5% | US$574.7b | US$197.03 | PB1.9x | E-1.7% | 2.3% | Banks | ||
WMT | US$60.72 | -0.9% | 26.3% | US$489.3b | US$65.14 | PE31.5x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$114.97 | 1.8% | 5.5% | US$456.2b | US$124.23 | PE12.7x | E-1.3% | 3.3% | Energy | ||
UNH | US$493.10 | -0.2% | 5.7% | US$454.6b | US$589.45 | PE20.3x | E9.6% | 1.5% | Healthcare | ||
A005930 | ₩80,800.00 | 1.9% | 27.8% | ₩537.7t | ₩95,575.00 | PE37.9x | E27.6% | 1.8% | Tech | ||
PG | US$162.61 | 0.4% | 10.8% | US$382.6b | US$169.11 | PE26.4x | E7.3% | 2.3% | Household | ||
JNJ | US$157.96 | 1.4% | 3.0% | US$380.6b | US$175.25 | PE28.6x | E9.1% | 3.0% | Pharmaceuticals & Biotech | ||
700 | HK$303.80 | 4.3% | -21.1% | HK$2.8t | HK$421.60 | PE22.7x | E15.1% | 1.1% | Media | ||
ORCL | US$125.27 | -3.1% | 38.2% | US$344.3b | US$137.02 | PE32.4x | E14.9% | 1.3% | Software | ||
MRK | US$131.75 | 6.4% | 25.6% | US$333.7b | US$136.01 | PE914.2x | E25.2% | 2.3% | Pharmaceuticals & Biotech | ||
COST | US$732.08 | -1.2% | 49.1% | US$324.7b | US$758.77 | PE47.8x | E7.4% | 0.6% | Consumer Retailing | ||
ABBV | US$180.35 | 2.3% | 14.1% | US$319.3b | US$183.88 | PE66.3x | E23.1% | 3.4% | Pharmaceuticals & Biotech | ||
BAC | US$37.81 | 2.9% | 31.9% | US$298.3b | US$37.54 | PB1.1x | E3.6% | 2.5% | Banks | ||
600519 | CN¥1,701.64 | -0.4% | -5.5% | CN¥2.1t | CN¥2,145.55 | PE30x | E14.5% | 1.5% | Food, Beverage & Tobacco | ||
CRM | US$301.38 | -1.5% | 53.3% | US$292.3b | US$334.14 | PE70.7x | E18.6% | 0.5% | Software | ||
CVX | US$156.35 | 1.2% | -2.8% | US$290.4b | US$175.90 | PE13.6x | E1.1% | 4.2% | Energy | ||
NESN | CHF96.00 | 1.5% | -14.3% | CHF251.6b | CHF108.80 | PE22.5x | E7.0% | 3.1% | Food, Beverage & Tobacco |